Anita SVEEN | Oslo University Hospital, Oslo
NatureRevClinOncol on Twitter: "New Review by Anita Sveen, Scott Kopetz & Ragnhild Lothe now live online - 'Biomarker-guided therapy for colorectal cancer: strength in complexity' https://t.co/e8rt4hPUBB https://t.co/CRcgi5bKuL" / Twitter
Kreftforskning, Helse | Anita (39) fra Toten har gjort kometkarriere – nå er hun blitt kåret til Årets forsker 2020
OUH - Molecular Oncology
Anita SVEEN | Oslo University Hospital, Oslo
Anita SVEEN | Oslo University Hospital, Oslo
OUH - News
2 "Anita Sveen" profiles | LinkedIn
Anita SVEEN | Oslo University Hospital, Oslo
OUH - News
Anita SVEEN | Oslo University Hospital, Oslo
Anita SVEEN | Oslo University Hospital, Oslo
En anerkjennelse av hele forskningsmiljøet - Nyheter, Forskning, Kreft - Dagens Medisin
Multilevel genomics of colorectal cancers with microsatellite instability—clinical impact of JAK1 mutations and consensus molecular subtype 1 – topic of research paper in Clinical medicine. Download scholarly article PDF and read for
Nasjonal Kreftsatsing Konferanse 2016 - 10.-11. mars - Anita Sveen - YouTube
NatureRevClinOncol on Twitter: "New Review by Anita Sveen, Scott Kopetz & Ragnhild Lothe now live online - 'Biomarker-guided therapy for colorectal cancer: strength in complexity' https://t.co/e8rt4hPUBB https://t.co/CRcgi5bKuL" / Twitter
OUH - Molecular Oncology
OUH - Group members
OUH - Molecular Oncology
OUH - News archive
Cognitass er fotfestet i hverdagen - Cognita
Anita SVEEN | Oslo University Hospital, Oslo
OUH - OUS-research.no
Preclinical drug screening identifies novel stratified treatment options according to the consensus molecular subtypes of colorectal cancer - K.G. Jebsen Colorectal Cancer Research Centre
OUH - News
OUH - News
Anita SVEEN | Oslo University Hospital, Oslo
En anerkjennelse av hele forskningsmiljøet - Nyheter, Forskning, Kreft - Dagens Medisin
